Rasilez(R), First-In-Class Direct Renin Inhibitor, Lowers High Blood Pressure More Effectively Than Diuretic In Obese Patients
September 7th, 2008 by samospsipsi
New clinical data analysis confirms that the first-in-class direct renin inhibitor Rasilez® (aliskiren), known as Tekturna® in the US, provides significantly greater blood pressure reductions in obese patients with high blood pressure compared to the diuretic hydrochlorothiazide (HCT) alone1.
More: continued here
